Back to Search
Start Over
Preclinical development of a chimeric antigen receptor TÂ cell therapy targeting FGFR4 in rhabdomyosarcoma.
- Source :
-
Cell reports. Medicine [Cell Rep Med] 2024 May 21; Vol. 5 (5), pp. 101586. Date of Electronic Publication: 2024 May 09. - Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 2666-3791
- Volume :
- 5
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Cell reports. Medicine
- Accession number :
- 38723625
- Full Text :
- https://doi.org/10.1016/j.xcrm.2024.101586